Personalized treatment concepts in extraocular cancer

Hedgehog signaling pathwayPTCH1 inhibits SMO in the absence of HH signaling ligand; when ligand is present, it binds to the transmembrane protein PTCH1, and the membrane spanning receptor SMO rescinds the PTCH1-mediated inhibition, leading to activation of the Gli transcription factor and entry into the nucleus to stimulate cell division and tumorigenesis. Several HPIs, such as vismodegib and sonidegib, bind SMO and inhibit reactivation of the HH pathway, available for cancer therapy. PTCH1, Patched-1; SMO, Smoothened; HH, Hedgehog; HPIs, hedgehog pathway inhibitors
Personalized treatment concepts in extraocular cancer

Publication

Personalized treatment concepts in extraocular cancer (2024) Sitong Ju, et al. Adv Ophthalmol Pract Res. 2024;4(2). Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates GLI1 GLI1 ncbigene_symbol GLI1 2735
Homo sapiens Primates Hedgehog HEDGEHOG famplex_relations DHH 50846
Homo sapiens Primates Hedgehog HEDGEHOG famplex_relations IHH 3549
Homo sapiens Primates Hedgehog HEDGEHOG famplex_relations SHH 6469
Homo sapiens Primates PTCH PTCH ncbigene_synonym PTCH1 5727
Homo sapiens Primates SUFU SUFU ncbigene_symbol SUFU 51684
Homo sapiens Primates GLI2 GLI2 ncbigene_symbol GLI2 2736
Homo sapiens Primates SMO SMO ncbigene_symbol SMO 6608
Homo sapiens Primates SMO SMO ncbigene_synonym SMOX 54498

Chemical mentions

Word Match MeSH Name ChEBI
Nucleus nucleus nucleus chebi:33252

Disease mentions

Word Match MeSH Name DOID